Table 1 Patient characteristics and metabolic and inflammatory markers before and 6 months after LAGB.

Number and sex of subjects

21 (7 M/14 F)

Age of subjects (years) (range)

36.9 (19–66)

BMI (kg/m²) (range)

43.1 ± 3.9 (37.2 − 50.5)

34.9 ± 4.4 (26.4–42.4)

<0.001

Weight loss (kg) (range)

24.7 ± 8.1 (18.5–50.5)

Aspartate amino transferase (units/L) (range)

30.7 ± 13.9 (20–83)

25.0 ± 6.5 (15–44)

0.07

Alanine amino transferase (units/L) (range)

36.8 ± 29.9 (15–121)

23.7 ± 10.4 (8–63)

<0.05

γ-Glutamyl transferase (units/L) (range)

34.4 ± 21.3 (18–111)

23.9 ± 10.4 (12–57)

<0.01

Fasting glucose (mg/dL)^a (range)

102 ± 16 (87–158)

89 ± 8 (69–106)

<0.001

Fasting insulin (µU/mL)^b (range)

21.4 ± 16.2 (6.3–71.5)

11.5 ± 8.0 (3.4–35.4)

<0.01

HOMA index (range)

5.6 ± 4.7 (1.4–18)

2.6 ± 2.0 (0.8–9.1)

<0.01

Glycated hemoglobin (%) (range)

5.7 ± 0.8 (5.1–6.3)

5.6 ± 0.7 (5.2–5.9)

NS^c

Leukocytes (10³/µL) (range)

7.5 ± 1.9 (5.0–12.2)

6.3 ± 1.4 (4.1–8.8)

<0.01

C-reactive protein (µg/dL) (range)

1.1 ± 0.7 (0.3–3.8)

0.6 ± 0.3 (0.1–1.4)

<0.05